Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | neutral amino acid transporter excitatory amino acid transporter | 0.1944 | 1 | 1 |
Schistosoma mansoni | sodium/dicarboxylate symporter-related | 0.0862 | 0.4395 | 0.4395 |
Schistosoma mansoni | sodium/dicarboxylate symporter-related | 0.0862 | 0.4395 | 0.4395 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.1944 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | Na+/H+-dicarboxylate symporter | 0.1944 | 1 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter excitatory amino acid transporter | 0.0862 | 0.4395 | 0.4372 |
Echinococcus granulosus | excitatory amino acid transporter 3 | 0.1944 | 1 | 1 |
Chlamydia trachomatis | glutamate symporter | 0.1944 | 1 | 1 |
Schistosoma mansoni | vesicular amine transporter | 0.0021 | 0.0041 | 0.0041 |
Treponema pallidum | glutamate transporter | 0.0862 | 0.4395 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 3 | 0.1944 | 1 | 1 |
Echinococcus multilocularis | sodium:dicarboxylate symporter | 0.1944 | 1 | 1 |
Echinococcus granulosus | sodium:dicarboxylate symporter | 0.1944 | 1 | 1 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0338 | 0.1681 | 0.1647 |
Schistosoma mansoni | nephrin | 0.0026 | 0.0068 | 0.0068 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0021 | 0.0041 | 0.0041 |
Loa Loa (eye worm) | excitatory amino acid transporter | 0.1944 | 1 | 1 |
Echinococcus granulosus | twitchin | 0.0026 | 0.0068 | 0.0028 |
Echinococcus multilocularis | Excitatory amino acid transporter | 0.1944 | 1 | 1 |
Schistosoma mansoni | cell adhesion molecule | 0.0028 | 0.0076 | 0.0076 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0315 | 0.1566 | 0.0038 |
Echinococcus multilocularis | roundabout 2 | 0.0033 | 0.0104 | 0.0063 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0076 | 0.0035 |
Onchocerca volvulus | Excitatory amino acid transporter homolog | 0.1944 | 1 | 1 |
Echinococcus granulosus | neutral amino acid transporter | 0.1944 | 1 | 1 |
Echinococcus granulosus | neutral amino acid transporter A | 0.1944 | 1 | 1 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0028 | 0.0076 | 0.0035 |
Echinococcus granulosus | roundabout 2 | 0.0033 | 0.0104 | 0.0063 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0021 | 0.0041 | 0.0041 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0338 | 0.1681 | 0.1647 |
Echinococcus granulosus | neutral amino acid transporter A | 0.1944 | 1 | 1 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.1944 | 1 | 1 |
Echinococcus granulosus | excitatory amino acid transporter 2 | 0.1944 | 1 | 1 |
Mycobacterium tuberculosis | Probable C4-dicarboxylate-transport transmembrane protein DctA | 0.1944 | 1 | 0.5 |
Echinococcus granulosus | Excitatory amino acid transporter | 0.1944 | 1 | 1 |
Echinococcus granulosus | neuroglian | 0.0026 | 0.0068 | 0.0028 |
Treponema pallidum | glutamate/aspartate transporter | 0.0862 | 0.4395 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 2 | 0.1944 | 1 | 1 |
Echinococcus multilocularis | Excitatory amino acid transporter | 0.1944 | 1 | 1 |
Echinococcus multilocularis | sodium:dicarboxylate symporter | 0.0862 | 0.4395 | 0.4372 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0104 | 0.0063 |
Echinococcus granulosus | excitatory amino acid transporter 2 | 0.1944 | 1 | 1 |
Schistosoma mansoni | solute carrier family 1 (glial high affinity glutamate transporter | 0.1944 | 1 | 1 |
Echinococcus granulosus | Excitatory amino acid transporter | 0.1944 | 1 | 1 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.1944 | 1 | 1 |
Echinococcus multilocularis | excitatory amino acid transporter 2 | 0.1944 | 1 | 1 |
Echinococcus multilocularis | neuroglian | 0.0026 | 0.0068 | 0.0028 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0104 | 0.0063 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 5.36 % | Antiplatelet activity against U46619-induced rabbit platelet aggregation in at 100 uM | ChEMBL. | 17689252 |
Activity (functional) | = 11.25 % | Antiplatelet activity against collagen-induced rabbit platelet aggregation at 100 uM | ChEMBL. | 17689252 |
Activity (functional) | = 13.95 % | Antiplatelet activity against arachidonic acid-induced rabbit platelet aggregation at 100 uM | ChEMBL. | 17689252 |
Activity (functional) | = 82.15 % | Antiplatelet activity against thrombin-induced rabbit platelet aggregation at 100 uM | ChEMBL. | 17689252 |
GI50 (functional) | = 43.5 uM | Antiproliferative activity against human NCI-H661 cells after 48 hrs by MTT assay | ChEMBL. | 17689252 |
GI50 (functional) | = 43.5 uM | Antiproliferative activity against human NCI-H661 cells after 48 hrs by MTT assay | ChEMBL. | 17689252 |
GI50 (functional) | > 50 uM | Antiproliferative activity against human MT2 cells after 48 hrs by MTT assay | ChEMBL. | 17689252 |
GI50 (functional) | > 50 uM | Antiproliferative activity against human NPC-Tw01 cells after 48 hrs by MTT assay | ChEMBL. | 17689252 |
GI50 (functional) | > 50 uM | Antiproliferative activity against human MT2 cells after 48 hrs by MTT assay | ChEMBL. | 17689252 |
IC50 (functional) | = 19.5 uM | Antiplatelet activity against collagen-induced rabbit platelet aggregation | ChEMBL. | 17689252 |
IC50 (functional) | = 49.8 uM | Antiproliferative activity against human MKN45 cells after 72 hrs by MTT assay | ChEMBL. | 23229058 |
IC50 (functional) | = 57.18 uM | Antiplatelet activity against U46619-induced rabbit platelet aggregation | ChEMBL. | 17689252 |
IC50 (functional) | = 67.8 uM | Antiplatelet activity against arachidonic acid-induced rabbit platelet aggregation | ChEMBL. | 17689252 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.